Skip to Main content Skip to Navigation
Journal articles

Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer

Ivan Shevchenko Svetlana Karakhanova Sabine Soltek Julia Link Jagadeesh Bayry 1, 2, 3, 4 Jens Werner Viktor Umansky 5 Alexandr Bazhin 
1 CRC - Centre de Recherche des Cordeliers
2 UPMC - Université Pierre et Marie Curie - Paris 6 - UFR de Médecine Pierre et Marie Curie
3 USPC - Université Sorbonne Paris Cité
4 INSERM - Institut National de la Santé et de la Recherche Médicale
5 DKFZ - German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg]
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-02455543
Contributor : Jagadeesh Bayry Connect in order to contact the contributor
Submitted on : Sunday, January 26, 2020 - 11:41:26 AM
Last modification on : Wednesday, September 28, 2022 - 4:20:11 PM

Links full text

openaccess

Identifiers

Collections

INSERM | UNIV-PARIS5 | UNIV-PARIS7 | UPMC | EPHE | CORDELIERS | PSL | SORBONNE-UNIVERSITE | SU-SCIENCES | UNIV-PARIS | UP-SANTE | SU-TI

Citation

Ivan Shevchenko, Svetlana Karakhanova, Sabine Soltek, Julia Link, Jagadeesh Bayry, et al.. Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer. International Journal of Cancer, Wiley, 2013, 133 (1), pp.98-107. ⟨10.1002/ijc.27990⟩. ⟨inserm-02455543⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

15